You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

pembrolizumab

( PEM broe LIZ ue mab )
Other Name(s): Keytruda®
Appearance: solution mixed into larger bags of fluids

Drug Formulary information is intended for use by healthcare professionals. It is not intended to be medical advice. Some of the information, including information about funding for cancer drugs, does not apply to all patients. Cancer treatment plans are unique to each patient. If you are a patient, please speak with your healthcare team to understand how this information applies to you.

Drug Monograph

Aug 2023
Eligibility Forms
pdf download Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and No Prior Ipilimumab pdf download Pembrolizumab - Advanced Melanoma (Unresectable or Metastatic Melanoma) and Prior Ipilimumab pdf download Pembrolizumab - Advanced or Metastatic Non-Small Cell Lung Cancer (Second or Subsequent Line) pdf download Pembrolizumab - First-line Treatment of Advanced Esophageal and Esophagogastric Junction Carcinoma pdf download Pembrolizumab - Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma pdf download Pembrolizumab - Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer pdf download Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck pdf download Pembrolizumab (Adult and Pediatric) - Relapsed cHL Post-Autologous Stem Cell Transplant or ASCT Ineligible pdf download Pembrolizumab (Adult Who Failed Prior Brentuximab Vedotin) - Relapsed cHL Post-ASCT or ASCT Ineligible pdf download Pembrolizumab - In Combo w Carboplatin and Paclitaxel for First-Line Metastatic Squamous NSCLC pdf download Pembrolizumab - In Combo w Platinum and Pemetrexed for First Line Metastatic Non-Squamous NSCLC pdf download Pembrolizumab - In Combination with Axitinib for First Line Advanced or Metastatic Renal Cell Carcinoma pdf download Pembrolizumab - First Line Treatment of MSI-H dMMR Metastatic Colorectal Cancer pdf download Pembrolizumab - Adjuvant Treatment for Renal Cell Carcinoma pdf download Pembrolizumab - Previously Treated MSI-H dMMR Advanced Endometrial Cancer pdf download Pembrolizumab - In Combination with Lenvatinib for Advanced Endometrial Cancer pdf download Pembrolizumab - In Combination with Lenvatinib for First-Line Advanced or Metastatic Renal Cell Carcinoma pdf download Pembrolizumab - Adjuvant Treatment for Completely Resected Stage III or IV Melanoma pdf download Pembrolizumab (Adult and Pediatric) - Adjuvant Treatment for Completely Resected Stage IIB or IIC Melanoma pdf download Pembrolizumab - Metastatic Persistent or Recurrent Carcinoma of the Cervix pdf download Pembrolizumab - Locally Recurrent Unresectable or Metastatic Triple Negative Breast Cancer pdf download Pembrolizumab - Previously Untreated High-Risk Early-Stage Triple Negative Breast Cancer

Patient Info Sheet

Apr 2023

What it is used for

  • For treating certain types of cancers such as skin (called melanoma), non-small cell lung, head and neck, renal cell (kidney), colorectal, endometrial, cervical, bladder or urinary tract, breast, esophageal and others. It is also used to treat some types of lymphomas.
  • Pembrolizumab is an immunotherapy drug. For more information on immunotherapy, click here


You might also be interested in